Advances in Health and Disease: Volume 48

This volume discusses the latest advancements in health and disease research, including the use of mTOR inhibitors in the treatment of haematological malignancies, synthetic and natural mTOR inhibitors for cancer, and the structure of mTOR and its signaling pathways. It also explores prostaglandins and their association with metabolic processes and periodontal maintenance therapy.

Format: Hardback
Length: 218 pages
Publication date: 23 November 2021
Publisher: Nova Science Publishers Inc

This comprehensive volume delves into the latest advancements in the field of health and disease research. In Chapter One, the focus lies on exploring the abnormal regulation of the mTOR pathway in haematological malignancies, highlighting the role of mTOR inhibitors in their treatment. Chapter Two delves into the development of synthetic and natural mTOR inhibitors as potential therapeutics for cancer and other diseases characterized by overactive mTOR signaling. Chapter Three examines the diverse range of cancer, neuroinflammatory, and neurodegenerative diseases, shedding light on their causes, significant signaling pathways, and profound effects on human health. Chapter Four provides a detailed overview of the structure and functioning of the mTOR pathway, including its upstream and downstream signaling mechanisms. Chapter Five explores the intricate relationship between prostaglandins and various physiological processes, such as ovulation, luteolysis, implantation, menstrual cycle, parturition, fallopian tube motility, and associated metabolic pathways. Furthermore, Chapter Five addresses the critical aspects of compliance, adjuvants, systemic health, and quality of life in connection with periodontal maintenance therapy. By presenting these comprehensive chapters, this volume serves as a valuable resource for researchers, healthcare professionals, and individuals seeking to stay informed about the latest developments in the field of health and disease.

ISBN-13: 9781685073756